De-escalation of biological therapy in Inflammatory bowel disease (IBD) and outcomes at week 52: a single centre experience

被引：0
|
作者：
Al-Talib, Ismaeel [1 ]
Iqbal, Majid [1 ]
Shaheen, Sirah [1 ]
Shingadia, Maya [1 ]
Slater, Jayne [1 ]
King, Dominic [1 ]
Rattehalli, Deepa [1 ]
De Silva, Shanika [1 ]
机构：
[1] Dudley Grp NHS Fdn Trust, Dudley, England
来源：
GUT | 2023年 / 72卷 / SUPPL_2期
关键词：
D O I：
10.1136/gutjnl-2023-BSG.132
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P60
引用
收藏
页码：A79 / A79
页数：1
相关论文
共 50 条
  • [1] De-escalation of immunomodulator and biological therapy in inflammatory bowel disease
    Chapman, Thomas P.
    Gomes, Catarina Frias
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01): : 63 - 79
  • [2] De-escalation of Therapy in Inflammatory Bowel Disease
    Frias Gomes C.
    Colombel J.-F.
    Torres J.
    Current Gastroenterology Reports, 2018, 20 (8)
  • [3] De-escalation of biological therapy in inflammatory bowel disease: Benefits and risks
    Fredericks, E.
    Watermeyer, G.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2019, 109 (10): : 745 - 749
  • [4] De-escalation of biological therapy in Inflammatory Bowel Disease patients following prior escalation
    Thomas, P.
    Smits, L.
    Groen, M. Te
    West, R.
    Russel, M.
    Jansen, J.
    Romkens, T.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S086 - S086
  • [5] De-escalation of medical therapy in inflammatory bowel disease
    Gomes, Catarina Frias
    Chapman, Thomas P.
    Satsangi, Jack
    CURRENT OPINION IN PHARMACOLOGY, 2020, 55 : 73 - 81
  • [6] De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
    Thomas, Pepijn W. A.
    Smits, Lisa J. T.
    Te Groen, Maarten
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    Romkens, Tessa E. H.
    Hoentjen, Frank
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (05) : 488 - 495
  • [7] De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease
    Miyatani, Yusuke
    Kobayashi, Taku
    GUT AND LIVER, 2023, 17 (02) : 181 - 189
  • [8] De-escalation of Combination Drug Therapy in Inflammatory Bowel Disease Patients
    Saleh, Adam A.
    Waghela, Rajdeepsingh
    Garza, Manuel
    Stading, Rachel
    Miroballi, Natalia
    Moskow, Joshua
    Thurston, Theresa
    Abraham, Bincy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S722 - S722
  • [9] Frequency and effectiveness of dose de-escalation of biologic therapy in Inflammatory Bowel Disease: The RAINBOW-IBD study of ENEIDA
    Rubin De Celix, C.
    Ricart, E.
    Martin-Arranz, M. D.
    de Francisco, R.
    Barrio, J.
    Mesonero, F.
    Gomollon, F.
    de Castro, L.
    Ramos, L.
    Garcia-Lopez, S.
    Arias, L.
    Manosa, M.
    Iglesias, E.
    Calvet, X.
    Pascual, I.
    Casanova, M. J.
    Perez-Calle, J. L.
    Giordano, A.
    Sierra, M.
    Vera, I.
    Navarro-Llavat, M.
    Lorente, R.
    Piqueras, M.
    Rivero, M.
    Guardiola, J.
    Esteve, M.
    Coronel, A. Fuentes
    Rodriguez-Lago, I.
    Ponferrada, A.
    Ber, Y.
    Tardillo, C.
    Marquez, L.
    Carpio, D.
    Taxonera, C.
    Bermejo, F.
    Busquets, D.
    Camps, B.
    Domenech, E.
    Chaparro, M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1557 - I1559
  • [10] Evaluation of de-escalation of anti-TNF-α therapy in inflammatory bowel disease
    Sedano Munoz, Rocio
    Quera Pino, Rodrigo
    Lubascher Correa, Jaime
    Pizarro Jofre, Gonzalo
    Simian Marin, Daniela
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (02): : 133 - 140
12345